Lindsay Kilburn, M.D. is an attending physician in Neuro-Oncology at Children's National Hospital and an Associate Professor of Pediatrics at the George Washington School of Medicine and Health Sciences. Dr. Kilburn specializes in the care of children with newly diagnosed and recurrent or progressive brain and spinal cord tumors and developing new therapies. Dr. Kilburn is Board Certified in both Pediatric Hematology/Oncology and Clinical Pharmacology making her well suited for her role as the Director of Experimental Therapeutics for the Brain Tumor Institute at Children's National. Her research focuses on developing clinical trials of targeted and combination therapies, personalized medicine, and low intensity focused ultrasound in an effort to improve survival outcomes and toxicity for children with brain tumors. She serves as the principal investigator and senior co-investigator for multiple, national early phase clinical trials for children with brain tumors and is actively involved in multiple clinical trials consortia including the Pacific NeuroOncology Consortium where she serves as site PI and the Pediatric Brain Tumor Consortium where she serves as the Chair of the Quality Assurance Committee and the Children's Oncology Group where she serves as co-chair for the high grade glioma committee.
